ElevateBio Scales Business Model with $525M Financing Round
- Posted by ISPE Boston
- On April 8, 2021
ElevateBio has raised $525 million in a Series C financing. According to its website, the company has created a business model addressing the most pressing challenges in the field of cell and gene therapy. Its suite of technologies includes gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering. With this financing, ElevateBio […]
Read More